ClinVar Miner

Submissions for variant NM_000448.3(RAG1):c.1438A>G (p.Ser480Gly)

dbSNP: rs772340017
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital & Research Centre RCV000171192 SCV000221389 likely pathogenic not provided criteria provided, single submitter research
Invitae RCV001852063 SCV002178445 uncertain significance Combined immunodeficiency with skin granulomas; Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive 2021-08-19 criteria provided, single submitter clinical testing This variant has been observed in individual(s) with clinical features of RAG1-related conditions (PMID: 24331380, 31130284). This variant is present in population databases (rs772340017, ExAC 0.001%). This sequence change replaces serine with glycine at codon 480 of the RAG1 protein (p.Ser480Gly). The serine residue is highly conserved and there is a small physicochemical difference between serine and glycine. ClinVar contains an entry for this variant (Variation ID: 191017). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt RAG1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV003993851 SCV004813596 likely pathogenic Severe combined immunodeficiency disease 2024-02-28 criteria provided, single submitter clinical testing Variant summary: RAG1 c.1438A>G (p.Ser480Gly) results in a non-conservative amino acid change in the encoded protein sequence. Four of four in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 251122 control chromosomes. c.1438A>G has been reported in the literature at a homozygous state in at-least two individuals affected with Severe Combined Immunodeficiency (Monies_2019, Schuetz_2023, Schuetz_2014). These data indicate that the variant is likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in about 55% of normal V(D)J recombination activity in human primary dermal fibroblasts (Schuetz_2023, Schuetz_2014). The following publications have been ascertained in the context of this evaluation (PMID: 31130284, 36279417, 24331380). ClinVar contains an entry for this variant (Variation ID: 191017). Based on the evidence outlined above, the variant was classified as likely pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.